drugset
drugset / Trial / NCT02307656

Taste Properties of Atazanavir and Cobicistat

NCT02307656 ↗

Phase 1 Completed 6 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelOther

Summary

The primary objective is to assess the taste properties of atazanavir (ATV) and cobicistat (COBI) alone and in combination as well as oral test formulations containing both ATV and COBI.

Timeline

Start
2014-12-12
Primary completion
2021-09-09
Completion
2021-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified — —
Subject Cobicistat Small molecule — —

Indications

No indication recorded.